Vioxx (rofecoxib), a new COX-2 inhibitor

      Merck is now promoting Vioxx (rofecoxib), a new COX-2 inhibitor...in the same class as Celebrex (celecoxib).

      These new drugs are comparable to NSAIDs for reducing pain and inflammation...but they might cause fewer GI problems.

      Vioxx comes in 12.5 and 25 mg tablets.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote